InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-11-18 00:00:00 ET · period of report 2022-09-27 · accession 0001209191-22-057939 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-11-18 2022-09-27+ CPIX Krogulski Kenneth Dir P - Purchase $2.49 +2,625 198.3K +1% +$6,549

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-10-03 P A 105 $2.54 197,600 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2 Common Common Stock 2022-10-04 P A 105 $2.61 197,705 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3 Common Common Stock 2022-10-05 P A 105 $2.58 197,810 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4 Common Common Stock 2022-10-06 P A 105 $2.65 197,915 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5 Common Common Stock 2022-10-07 P A 105 $2.66 198,020 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6 Common Common Stock 2022-10-10 P A 105 $2.53 198,125 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7 Common Common Stock 2022-10-11 P A 105 $2.48 198,230 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8 Common Common Stock 2022-10-13 P A 105 $2.38 198,440 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9 Common Common Stock 2022-10-14 P A 105 $2.31 198,545 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10 Common Common Stock 2022-10-17 P A 105 $2.33 198,650 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11 Common Common Stock 2022-10-18 P A 105 $2.46 198,755 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12 Common Common Stock 2022-10-19 P A 105 $2.42 198,860 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13 Common Common Stock 2022-10-20 P A 105 $2.44 198,965 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14 Common Common Stock 2022-10-21 P A 105 $2.49 199,070 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15 Common Common Stock 2022-10-24 P A 105 $2.38 199,175 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16 Common Common Stock 2022-10-25 P A 105 $2.44 199,280 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17 Common Common Stock 2022-10-26 P A 105 $2.42 199,385 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18 Common Common Stock 2022-10-27 P A 105 $2.49 199,490 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19 Common Common Stock 2022-10-28 P A 105 $2.52 199,595 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20 Common Common Stock 2022-10-31 P A 105 $2.54 199,700 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21 Common Common Stock 2022-09-30 P A 105 $2.61 197,495 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
22 Common Common Stock 2022-09-29 P A 105 $2.51 197,390 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
23 Common Common Stock 2022-09-28 P A 105 $2.52 197,285 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
24 Common Common Stock 2022-09-27 P A 105 $2.57 197,180 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
25 Common Common Stock 2022-10-12 P A 105 $2.49 198,335 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.